SlideShare ist ein Scribd-Unternehmen logo
1 von 17
Downloaden Sie, um offline zu lesen
Dissemination of HTA products. New
                 lines of action
                                                                                                    Casal Acción, Beatriz
                                                                                                    López García, Marisa
                                                                                                    Varela Lema, Leonor
                                                                                                    Alcázar Alcázar, Raimundo


“This document was elaborated within the collaboration framework established by Quality Plan for the National Health System of the Ministry of Health,
Social Services and Equality, under the collaboration agreement signed between the Institute of Health Carlos III, an autonomous organism part of the
Spanish Ministry of Economy and Competitiveness, and the A Coruña University Complex Foundation”
Scope


         HTA consolidated its role of providing
          the policy-makers and health-
          managers with the best available
          evidence.
         New audiences: health professionals,
          academics, certain industries,
          patients and the general public.
         Difficulties to bridge the gap between
           agencies and our target audience.
Background
                                                         National level


 The dissemination of HTA products has been a
  strategic area of interest for avalia-t &
  Aunet’s agencies.
 Avalia-t has led Aunet’s Working Group of
  experts in the Area of Dissemination, 2006.
    “Strategies for the diffusion and dissemination of
    health technology assessment products”
    (Sobrido, et al 2009) Avaliat&Aunets.
 It sets a continuous line of collaboration in
  Aunets.
Background
                                                                        International level

 International level
     The International Network of Agencies for HTA (INAHTA):
          WG2 Communication (2002)
     The European Network for Health Technology Assessment (EUnetHTA):
          WP2 Communications (2006-2008)
          WP2 Dissemination (2010-2012)
     Institute of Health Economics (IHE) “Effective Dissemination of Findings from
      Research” (2008).

Some studies show that certain reports do not impact as intended in the target audience:

     [Demands and expectations for health technology assessment: qualitative analysis from the
      perspective of decision makers and clinicians] Varela-Lema L et al.2011.

     Maximizing the impact of systematic reviews in health care decision making: a systematic
      scoping review of knowledge-translation resources. Chambers D. 2011.
Objectives


  Evaluate policies and initiatives for the
   dissemination of HTA products (National &
   International ).
  Assess to what degree the recommendations
   made by the Diffusion Responsible Working
   Group (Sobrido et al1, 2009) have been
   implemented within the Spanish Network HTA
   Agencies diffusion policies.
  Identify improvement areas and propose new
   strategies and lines of action.



      1-Sobrido Prieto M, González Guitián C, Cerdá Mota T, Group of technicians and experts in documentation and diffusion/dissemination belonging to the
      Spanish Health Technology Assessment Agencies & Units. Strategies for the diffusion and dissemination of health technology assessment (HTA) products.
      Madrid: Ministry of Science & Innovation; 2009. Report No.: avalia-t Núm. 2007 / 07.
Evaluate policies and initiatives for the dissemination of HTA products (I)




 Which organizations?
      Spanish Network of HTA Agencies & Units (AUnETS).
      International Network of Agencies for Health Technology Assessment (INAHTA).


 Who?
      Technical group:
          Unit of Documentation of avalia-t: bibliographic review and detailed analysis.
      Working group:
          Documentalist and diffusion responsibles of Spanish Network of HTA Agencies
         (Aunet’s Working Group): reviewed de draft and agreed upon the recommendations.
Evaluate policies and initiatives for the dissemination of HTA products (II)


  How?

       Bibliographic review: updating search
        (Sobrido et al 2009).
         Medline (PubMed), HTA of CRD database,
          ISI web of Science and Spanish Medical Index


       Analysis of the organizations.
         -National: detailed specific questionnaire
          -International: agencies' websites & INAHTA’s
             website
Evaluate policies and initiatives for the dissemination of HTA products (III)


   What aspects?
        Type of documents
            HTA Reports (HTAr)
            Rapid Assessment (RA)
            Early Warning Brief Reports (EWBr)
            Clinical Practice Guidelines (CPG)
            Other types: Methodological documents, glossary…
        Targeted audience
            Decision Makers: Policy Makers & Health Managers (PM)
            Health Professionals (HP)
            Patients and General Public (Cz)
            Medical & Pharmaceutical Industry (MI)
        Strategies
            Documental Support
            Identification of techniques and processes of diffusion and dissemination
Results: Target Audience
                                            National


 All agencies directed it’s documents to
  the decision makers, physicians and
  professional associations

 Agencies produced citizen versions: 75%

 Considered the Medical and
  Pharmaceutical Industry as a target
  audience: 25%
Results: Target Audience
                                         International

 All agencies directed it’s documents
  to the decision makers

 Health Professionals: 93%

 Agencies produced citizen versions:
  14%

 Medical and Pharmaceutical
  Industry: 8.7%
Type of documents
                                                  National


   HTA reports: 100%
   Rapid Assessment: 100%
   Clinical Practice Guidelines: 87.5%
   Early Warning Brief Reports: 50%
   Other types: 37.5%
     • Methodological Documents
     • Versions for patients, carers & families
     • HTA Glossary
     • Evaluative Research Reports
Type of documents
                                                    International


   HTA reports: 100%
   Rapid Assessment: 45%
   Clinical Practice Guidelines: 24%
   Early Warning Brief Reports: 50 %
   Other types: 31.5%
     •   Methodological Documents
     •   Versions for patients, carers & families
     •   HTA Glossary
Dissemination Policies
                                               National & International
 Channels
        100% / 100% agencies maintained and updated their website.
        50% / 65% agencies published News Bulletins.
        35% / 26% Web 2.0, Twitter being the most used.
        50% / 45% used alert systems or RSS systematically.
 Formats (national)
      100% undertook technical sessions
       (Hospitals, Primary Care, Healthcare Administration…).
      100% Published medical articles in specialized journals and reported in
       congresses.
      All published HTA reports are collected in main International databases
       (CRD, Cochrane & Cochrane Library Plus…).
 Dissemination (national)
      75%: Agencies have a person responsible for the dissemination area.
Implementation of recommendations about policies and strategies
of dissemination 2011


Versions and channels
•A short version for Policy Makers and Health Managers has been developed by avalia-t
and proposed as reference for AUnETS’ working group.
•Currently 75% of AUnETS Agencies have elaborated patient and family versions (0% in
2009).
•Health professionals: indexed articles in Medline (AUnETS’s agencies) has not varied in
relevant number of data references between 2009 and 2011.
•50 % Agencies edit an e-mail newsletter (which has been maintained between 2009 and
the present day).

Impact measure
•According to the results of an external analysis 1, the perceived impact of HTA reports, in
Spain, is low (scarcely cited in investigation papers).

1Parada-Martinez A, Gutierrez-Ibarluzea I. Evaluación del impacto bibliográfico de las agencias y unidades españolas de evaluación de tecnologías sanitarias.
Barcelona: Agència d`Informació, Avaluació i Qualitat en Salut de Cataluña; 2011
Recommendations

VISIBILITY:
•Creating and maintaining a common database of ongoing projects to facilitate
inter-agency coordination and the creation of synergies.
•A scientific repository operated and maintained jointly by the AUnETS
network should be implemented.
VERSIONS:
•A short version for HTA products, should be systematically created.
•A scientific paper targeted at the research audience.
DOCUMENTAL SUPPORTS:
•Use of electronic support whenever possible: browseble PDF format.
•New supports: e-books, format for mobile devices…
Recommendations

CHANNELS
•Use of web 2.0 and social networking sites should multiply the point access
to the reports.



•The request of a space for HTA products within the national journals
specialized in the field of health-care administration and management.
•Issuing a common electronic bulletin for HTA agencies or a blog.
•Boost AuNets website in order to give it more functionalities and make it
more friendly for internal users and citizens.
GLOSSARY
•Normalize the denomination of documents by a common glossary.
 We expect that all these
  recommendations will be
  useful and help us to bridge
  the gap between the
  agencies and our final
  audience.



Thanks for your attention!


    Contact person: Marisa López
                                   To Ceres
              avalia-t@sergas.es

Weitere ähnliche Inhalte

Was ist angesagt?

Real World Evidence Industry Snapshot
Real World Evidence Industry SnapshotReal World Evidence Industry Snapshot
Real World Evidence Industry SnapshotEnka Birce
 
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICAHEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICAOffice of Health Economics
 
Disease Management and Disease Registries
Disease Management and Disease RegistriesDisease Management and Disease Registries
Disease Management and Disease RegistriesTanveer Abbas
 
Precise Patient Registries for Clinical Research and Population Management
Precise Patient Registries for Clinical Research and Population ManagementPrecise Patient Registries for Clinical Research and Population Management
Precise Patient Registries for Clinical Research and Population ManagementDale Sanders
 
Call for Malaria ACTs appraisal
Call for Malaria ACTs appraisalCall for Malaria ACTs appraisal
Call for Malaria ACTs appraisalJan-Cedric Hansen
 
Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Office of Health Economics
 
Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...
Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...
Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...Office of Health Economics
 
Mini-Course Starter Kits
Mini-Course Starter KitsMini-Course Starter Kits
Mini-Course Starter KitsEUPATI
 
Health Technology Assessment
Health Technology AssessmentHealth Technology Assessment
Health Technology AssessmentEUPATI
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOffice of Health Economics
 
Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making Office of Health Economics
 
2016_The exchangeability of self-reports and administrative health care resou...
2016_The exchangeability of self-reports and administrative health care resou...2016_The exchangeability of self-reports and administrative health care resou...
2016_The exchangeability of self-reports and administrative health care resou...Cindy Noben
 
2015 Edition Proposed Rule Modifications to the ONC Health IT Certification ...
2015 Edition Proposed RuleModifications to the ONC Health IT Certification ...2015 Edition Proposed RuleModifications to the ONC Health IT Certification ...
2015 Edition Proposed Rule Modifications to the ONC Health IT Certification ...Brian Ahier
 
HIT Policy Committee FDASIA Update
HIT Policy Committee FDASIA UpdateHIT Policy Committee FDASIA Update
HIT Policy Committee FDASIA UpdateBrian Ahier
 
Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...Office of Health Economics
 
Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health servicespending decisions: A qualitative ...Opportunity costs and local health servicespending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...Kerry Sheppard
 

Was ist angesagt? (17)

Real World Evidence Industry Snapshot
Real World Evidence Industry SnapshotReal World Evidence Industry Snapshot
Real World Evidence Industry Snapshot
 
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICAHEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
 
Disease Management and Disease Registries
Disease Management and Disease RegistriesDisease Management and Disease Registries
Disease Management and Disease Registries
 
Precise Patient Registries for Clinical Research and Population Management
Precise Patient Registries for Clinical Research and Population ManagementPrecise Patient Registries for Clinical Research and Population Management
Precise Patient Registries for Clinical Research and Population Management
 
Call for Malaria ACTs appraisal
Call for Malaria ACTs appraisalCall for Malaria ACTs appraisal
Call for Malaria ACTs appraisal
 
Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...
 
Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...
Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...
Presentation by Paula Lorgelly - Beyond QALYs: A Quantum Leap Forward or a Le...
 
Mini-Course Starter Kits
Mini-Course Starter KitsMini-Course Starter Kits
Mini-Course Starter Kits
 
Health Technology Assessment
Health Technology AssessmentHealth Technology Assessment
Health Technology Assessment
 
107 satellife
107 satellife107 satellife
107 satellife
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making
 
2016_The exchangeability of self-reports and administrative health care resou...
2016_The exchangeability of self-reports and administrative health care resou...2016_The exchangeability of self-reports and administrative health care resou...
2016_The exchangeability of self-reports and administrative health care resou...
 
2015 Edition Proposed Rule Modifications to the ONC Health IT Certification ...
2015 Edition Proposed RuleModifications to the ONC Health IT Certification ...2015 Edition Proposed RuleModifications to the ONC Health IT Certification ...
2015 Edition Proposed Rule Modifications to the ONC Health IT Certification ...
 
HIT Policy Committee FDASIA Update
HIT Policy Committee FDASIA UpdateHIT Policy Committee FDASIA Update
HIT Policy Committee FDASIA Update
 
Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...
 
Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health servicespending decisions: A qualitative ...Opportunity costs and local health servicespending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...
 

Ähnlich wie Dissemination of HTA products. New lines of action. Marisa Lopez.

Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.REBRATSoficial
 
International Classification of Health Interventions - development phase 2014...
International Classification of Health Interventions - development phase 2014...International Classification of Health Interventions - development phase 2014...
International Classification of Health Interventions - development phase 2014...Bedirhan Ustun
 
JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene EU_CHRODIS
 
Cadth 2015 a7 cnesh panel slides htx v3 john
Cadth 2015 a7 cnesh panel slides htx v3 johnCadth 2015 a7 cnesh panel slides htx v3 john
Cadth 2015 a7 cnesh panel slides htx v3 johnCADTH Symposium
 
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?Jackie Brusch
 
Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010Gezonde scepsis
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldjangeissler
 
Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15CADTH Symposium
 
The PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki PageThe PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki PageAngelo Tinazzi
 
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016ipposi
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017ipposi
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Biocat, BioRegion of Catalonia
 
Taking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population HealthTaking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population HealthPractical Playbook
 
IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...
IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...
IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...RELACSIS-OPS Red
 

Ähnlich wie Dissemination of HTA products. New lines of action. Marisa Lopez. (20)

Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
 
Jornadas #PatientInHTA · Ana Toledo
Jornadas #PatientInHTA · Ana ToledoJornadas #PatientInHTA · Ana Toledo
Jornadas #PatientInHTA · Ana Toledo
 
International Classification of Health Interventions - development phase 2014...
International Classification of Health Interventions - development phase 2014...International Classification of Health Interventions - development phase 2014...
International Classification of Health Interventions - development phase 2014...
 
JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene JA-CHRODIS at the 18th Nursing Research Conferene
JA-CHRODIS at the 18th Nursing Research Conferene
 
Cadth 2015 a7 cnesh panel slides htx v3 john
Cadth 2015 a7 cnesh panel slides htx v3 johnCadth 2015 a7 cnesh panel slides htx v3 john
Cadth 2015 a7 cnesh panel slides htx v3 john
 
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
 
Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010Hilda Bastian - Selling Sickness 2010
Hilda Bastian - Selling Sickness 2010
 
Jornadas #PatientInHTA · Isabel Amo
Jornadas #PatientInHTA · Isabel AmoJornadas #PatientInHTA · Isabel Amo
Jornadas #PatientInHTA · Isabel Amo
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15
 
The PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki PageThe PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki Page
 
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
PMI Masterclass - Derick Mitchell IPPOSI - October 19th 2016
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
Jornadas #PatientInHTA · Valentina Strammiello
Jornadas #PatientInHTA · Valentina StrammielloJornadas #PatientInHTA · Valentina Strammiello
Jornadas #PatientInHTA · Valentina Strammiello
 
The application of new technologies and IT in Health: standards as infrastruc...
The application of new technologies and IT in Health: standards as infrastruc...The application of new technologies and IT in Health: standards as infrastruc...
The application of new technologies and IT in Health: standards as infrastruc...
 
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
Presentation Moebio & d·HEALTH Barcelona & CRAASH 2018
 
Taking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population HealthTaking Collaborations to Scale to Improve Population Health
Taking Collaborations to Scale to Improve Population Health
 
IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...
IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...
IX Reunion Relacsis 2019 ARG - Marcelo Dagostino - Information Systems for He...
 
Andrew Searles
Andrew SearlesAndrew Searles
Andrew Searles
 

Mehr von HTAi Bilbao 2012

How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...HTAi Bilbao 2012
 
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...HTAi Bilbao 2012
 
Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...HTAi Bilbao 2012
 
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The use of ‘colloquial evidence’ in HTA:  the experience of NICE The use of ‘colloquial evidence’ in HTA:  the experience of NICE
The use of ‘colloquial evidence’ in HTA: the experience of NICE HTAi Bilbao 2012
 
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...HTAi Bilbao 2012
 
Challenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careChallenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careHTAi Bilbao 2012
 
Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...HTAi Bilbao 2012
 
Assessing the International Use
Assessing the International Use Assessing the International Use
Assessing the International Use HTAi Bilbao 2012
 
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...HTAi Bilbao 2012
 
On the outside looking in.
On the outside looking in. On the outside looking in.
On the outside looking in. HTAi Bilbao 2012
 
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...HTAi Bilbao 2012
 
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...HTAi Bilbao 2012
 
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseThe eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseHTAi Bilbao 2012
 
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportEvaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportHTAi Bilbao 2012
 
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...HTAi Bilbao 2012
 
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationBevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationHTAi Bilbao 2012
 
Azienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineAzienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineHTAi Bilbao 2012
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...HTAi Bilbao 2012
 
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...HTAi Bilbao 2012
 

Mehr von HTAi Bilbao 2012 (20)

How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
 
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
 
Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...
 
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The use of ‘colloquial evidence’ in HTA:  the experience of NICE The use of ‘colloquial evidence’ in HTA:  the experience of NICE
The use of ‘colloquial evidence’ in HTA: the experience of NICE
 
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...
 
Challenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careChallenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated care
 
Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...
 
Assessing the International Use
Assessing the International Use Assessing the International Use
Assessing the International Use
 
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
 
On the outside looking in.
On the outside looking in. On the outside looking in.
On the outside looking in.
 
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
 
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...
 
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseThe eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
 
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportEvaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
 
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...
 
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationBevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
 
Azienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineAzienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of Udine
 
HTAi in hospitals
HTAi in hospitalsHTAi in hospitals
HTAi in hospitals
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
 
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
 

Kürzlich hochgeladen

Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 

Kürzlich hochgeladen (20)

Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 

Dissemination of HTA products. New lines of action. Marisa Lopez.

  • 1. Dissemination of HTA products. New lines of action Casal Acción, Beatriz López García, Marisa Varela Lema, Leonor Alcázar Alcázar, Raimundo “This document was elaborated within the collaboration framework established by Quality Plan for the National Health System of the Ministry of Health, Social Services and Equality, under the collaboration agreement signed between the Institute of Health Carlos III, an autonomous organism part of the Spanish Ministry of Economy and Competitiveness, and the A Coruña University Complex Foundation”
  • 2. Scope  HTA consolidated its role of providing the policy-makers and health- managers with the best available evidence.  New audiences: health professionals, academics, certain industries, patients and the general public.  Difficulties to bridge the gap between agencies and our target audience.
  • 3. Background National level  The dissemination of HTA products has been a strategic area of interest for avalia-t & Aunet’s agencies.  Avalia-t has led Aunet’s Working Group of experts in the Area of Dissemination, 2006. “Strategies for the diffusion and dissemination of health technology assessment products” (Sobrido, et al 2009) Avaliat&Aunets.  It sets a continuous line of collaboration in Aunets.
  • 4. Background International level  International level  The International Network of Agencies for HTA (INAHTA):  WG2 Communication (2002)  The European Network for Health Technology Assessment (EUnetHTA):  WP2 Communications (2006-2008)  WP2 Dissemination (2010-2012)  Institute of Health Economics (IHE) “Effective Dissemination of Findings from Research” (2008). Some studies show that certain reports do not impact as intended in the target audience:  [Demands and expectations for health technology assessment: qualitative analysis from the perspective of decision makers and clinicians] Varela-Lema L et al.2011.  Maximizing the impact of systematic reviews in health care decision making: a systematic scoping review of knowledge-translation resources. Chambers D. 2011.
  • 5. Objectives  Evaluate policies and initiatives for the dissemination of HTA products (National & International ).  Assess to what degree the recommendations made by the Diffusion Responsible Working Group (Sobrido et al1, 2009) have been implemented within the Spanish Network HTA Agencies diffusion policies.  Identify improvement areas and propose new strategies and lines of action. 1-Sobrido Prieto M, González Guitián C, Cerdá Mota T, Group of technicians and experts in documentation and diffusion/dissemination belonging to the Spanish Health Technology Assessment Agencies & Units. Strategies for the diffusion and dissemination of health technology assessment (HTA) products. Madrid: Ministry of Science & Innovation; 2009. Report No.: avalia-t Núm. 2007 / 07.
  • 6. Evaluate policies and initiatives for the dissemination of HTA products (I) Which organizations?  Spanish Network of HTA Agencies & Units (AUnETS).  International Network of Agencies for Health Technology Assessment (INAHTA). Who?  Technical group:  Unit of Documentation of avalia-t: bibliographic review and detailed analysis.  Working group:  Documentalist and diffusion responsibles of Spanish Network of HTA Agencies (Aunet’s Working Group): reviewed de draft and agreed upon the recommendations.
  • 7. Evaluate policies and initiatives for the dissemination of HTA products (II) How?  Bibliographic review: updating search (Sobrido et al 2009). Medline (PubMed), HTA of CRD database, ISI web of Science and Spanish Medical Index  Analysis of the organizations. -National: detailed specific questionnaire -International: agencies' websites & INAHTA’s website
  • 8. Evaluate policies and initiatives for the dissemination of HTA products (III) What aspects?  Type of documents  HTA Reports (HTAr)  Rapid Assessment (RA)  Early Warning Brief Reports (EWBr)  Clinical Practice Guidelines (CPG)  Other types: Methodological documents, glossary…  Targeted audience  Decision Makers: Policy Makers & Health Managers (PM)  Health Professionals (HP)  Patients and General Public (Cz)  Medical & Pharmaceutical Industry (MI)  Strategies  Documental Support  Identification of techniques and processes of diffusion and dissemination
  • 9. Results: Target Audience National  All agencies directed it’s documents to the decision makers, physicians and professional associations  Agencies produced citizen versions: 75%  Considered the Medical and Pharmaceutical Industry as a target audience: 25%
  • 10. Results: Target Audience International  All agencies directed it’s documents to the decision makers  Health Professionals: 93%  Agencies produced citizen versions: 14%  Medical and Pharmaceutical Industry: 8.7%
  • 11. Type of documents National  HTA reports: 100%  Rapid Assessment: 100%  Clinical Practice Guidelines: 87.5%  Early Warning Brief Reports: 50%  Other types: 37.5% • Methodological Documents • Versions for patients, carers & families • HTA Glossary • Evaluative Research Reports
  • 12. Type of documents International  HTA reports: 100%  Rapid Assessment: 45%  Clinical Practice Guidelines: 24%  Early Warning Brief Reports: 50 %  Other types: 31.5% • Methodological Documents • Versions for patients, carers & families • HTA Glossary
  • 13. Dissemination Policies National & International Channels  100% / 100% agencies maintained and updated their website.  50% / 65% agencies published News Bulletins.  35% / 26% Web 2.0, Twitter being the most used.  50% / 45% used alert systems or RSS systematically. Formats (national)  100% undertook technical sessions (Hospitals, Primary Care, Healthcare Administration…).  100% Published medical articles in specialized journals and reported in congresses.  All published HTA reports are collected in main International databases (CRD, Cochrane & Cochrane Library Plus…). Dissemination (national)  75%: Agencies have a person responsible for the dissemination area.
  • 14. Implementation of recommendations about policies and strategies of dissemination 2011 Versions and channels •A short version for Policy Makers and Health Managers has been developed by avalia-t and proposed as reference for AUnETS’ working group. •Currently 75% of AUnETS Agencies have elaborated patient and family versions (0% in 2009). •Health professionals: indexed articles in Medline (AUnETS’s agencies) has not varied in relevant number of data references between 2009 and 2011. •50 % Agencies edit an e-mail newsletter (which has been maintained between 2009 and the present day). Impact measure •According to the results of an external analysis 1, the perceived impact of HTA reports, in Spain, is low (scarcely cited in investigation papers). 1Parada-Martinez A, Gutierrez-Ibarluzea I. Evaluación del impacto bibliográfico de las agencias y unidades españolas de evaluación de tecnologías sanitarias. Barcelona: Agència d`Informació, Avaluació i Qualitat en Salut de Cataluña; 2011
  • 15. Recommendations VISIBILITY: •Creating and maintaining a common database of ongoing projects to facilitate inter-agency coordination and the creation of synergies. •A scientific repository operated and maintained jointly by the AUnETS network should be implemented. VERSIONS: •A short version for HTA products, should be systematically created. •A scientific paper targeted at the research audience. DOCUMENTAL SUPPORTS: •Use of electronic support whenever possible: browseble PDF format. •New supports: e-books, format for mobile devices…
  • 16. Recommendations CHANNELS •Use of web 2.0 and social networking sites should multiply the point access to the reports. •The request of a space for HTA products within the national journals specialized in the field of health-care administration and management. •Issuing a common electronic bulletin for HTA agencies or a blog. •Boost AuNets website in order to give it more functionalities and make it more friendly for internal users and citizens. GLOSSARY •Normalize the denomination of documents by a common glossary.
  • 17.  We expect that all these recommendations will be useful and help us to bridge the gap between the agencies and our final audience. Thanks for your attention! Contact person: Marisa López To Ceres avalia-t@sergas.es